Elypta
Elypta Announces Urine Biomarker Study Demonstrating Improved Five-Year Cancer Risk Prediction in 5,436 Adults
Pre-specified high-risk group held 54% of cancers over five years STOCKHOLM, Nov. 11, 2026 — A urine profile of three glycosaminoglycan disacharrides…